An in vivo model allowing continuous observation of human vascular formation in the same animal over time

• Published in: Scientific reports 2021-01, Vol.11 (1), p.745-745, Article 745
• Main Authors: Tsukada, Yohei, Muramatsu, Fumitaka, Hayashi, Yumiko, Inagaki, Chiaki, Su, Hang, Iba, Tomohiro, Kidoya, Hiroyasu, Takakura, Nobuyuki
• Format: Article
• Language: English
• Subjects: 631/1647/245; 631/1647/328; 631/337; 631/80; Angiogenesis; Blood vessels; Humanities and Social Sciences; Immunosuppressive agents; Molecular modelling; multidisciplinary; Science; Science (multidisciplinary); Transplantation
• ISSN: 2045-2322; 2045-2322
• DOI: 10.1038/s41598-020-80497-6

Angiogenesis contributes to numerous pathological conditions. Understanding the molecular mechanisms of angiogenesis will offer new therapeutic opportunities. Several experimental in vivo models that better represent the pathological conditions have been generated for this purpose in mice, but it is difficult to translate results from mouse to human blood vessels. To understand human vascular biology and translate findings into human research, we need human blood vessel models to replicate human vascular physiology. Here, we show that human tumor tissue transplantation into a cranial window enables engraftment of human blood vessels in mice. An in vivo imaging technique using two-photon microscopy allows continuous observation of human blood vessels until at least 49 days after tumor transplantation. These human blood vessels make connections with mouse blood vessels as shown by the finding that lectin injected into the mouse tail vein reaches the human blood vessels. Finally, this model revealed that formation and/or maintenance of human blood vessels depends on VEGFR2 signaling. This approach represents a useful tool to study molecular mechanisms of human blood vessel formation and to test effects of drugs that target human blood vessels in vivo to show proof of concept in a preclinical model.